332 related articles for article (PubMed ID: 18598275)
1. A novel therapeutic paradigm to treat congenital hypothyroidism.
Mathai S; Cutfield WS; Gunn AJ; Webster D; Jefferies C; Robinson E; Hofman P
Clin Endocrinol (Oxf); 2008 Jul; 69(1):142-7. PubMed ID: 18598275
[TBL] [Abstract][Full Text] [Related]
2. [Congenital hypothyroidism. Therapeutic strategy at the early stage of treatment].
Touati G; Léger J; Czernichow P
Arch Fr Pediatr; 1991; 48(7):461-5. PubMed ID: 1929745
[TBL] [Abstract][Full Text] [Related]
3. Head circumference and linear growth during the first 3 years in treated congenital hypothyroidism in relation to aetiology and initial biochemical severity.
Ng SM; Wong SC; Didi M
Clin Endocrinol (Oxf); 2004 Jul; 61(1):155-9. PubMed ID: 15212659
[TBL] [Abstract][Full Text] [Related]
4. Initial treatment dose of L-thyroxine in congenital hypothyroidism.
Selva KA; Mandel SH; Rien L; Sesser D; Miyahira R; Skeels M; Nelson JC; Lafranchi SH
J Pediatr; 2002 Dec; 141(6):786-92. PubMed ID: 12461494
[TBL] [Abstract][Full Text] [Related]
5. Adjustment of L-T4 substitutive therapy in pregnant women with subclinical, overt or post-ablative hypothyroidism.
Verga U; Bergamaschi S; Cortelazzi D; Ronzoni S; Marconi AM; Beck-Peccoz P
Clin Endocrinol (Oxf); 2009 May; 70(5):798-802. PubMed ID: 18771569
[TBL] [Abstract][Full Text] [Related]
6. Effect of high versus low initial doses of L-thyroxine for congenital hypothyroidism on thyroid function and somatic growth.
Jones JH; Gellén B; Paterson WF; Beaton S; Donaldson MD
Arch Dis Child; 2008 Nov; 93(11):940-4. PubMed ID: 18456702
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal assessment of levo-thyroxine therapy for congenital hypothyroidism: relationship with aetiology, bone maturation and biochemical features.
Delvecchio M; Faienza MF; Acquafredda A; Zecchino C; Peruzzi S; Cavallo L
Horm Res; 2007; 68(3):105-12. PubMed ID: 17337903
[TBL] [Abstract][Full Text] [Related]
8. Update of newborn screening and therapy for congenital hypothyroidism.
; Rose SR; ; Brown RS; ; Foley T; Kaplowitz PB; Kaye CI; Sundararajan S; Varma SK
Pediatrics; 2006 Jun; 117(6):2290-303. PubMed ID: 16740880
[TBL] [Abstract][Full Text] [Related]
9. Multivariate analysis on factors affecting suppression of thyroid-stimulating hormone in treated congenital hypothyroidism.
Ng SM; Wong SC; Isherwood DM; Smith CS; Didi M
Horm Res; 2004; 62(5):245-51. PubMed ID: 15499223
[TBL] [Abstract][Full Text] [Related]
10. Thyrotropin screening for congenital hypothyroidism in Queen Sirikit National Institute of Child Health, Thailand (during year 1995-2000).
Churesigaew S; Ratrisawasdi V; Thaeramanophab S
J Med Assoc Thai; 2002 Jul; 85(7):782-8. PubMed ID: 12296410
[TBL] [Abstract][Full Text] [Related]
11. Alphafetoprotein in screening for congenital hypothyroidism.
Shawky RM; Abd el-Fattah S; el-din Azzam ME; Rafik MM; Osman A
East Mediterr Health J; 2001; 7(1-2):171-80. PubMed ID: 12596967
[TBL] [Abstract][Full Text] [Related]
12. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism.
Salerno M; Militerni R; Bravaccio C; Micillo M; Capalbo D; Di MS; Tenore A
Thyroid; 2002 Jan; 12(1):45-52. PubMed ID: 11838730
[TBL] [Abstract][Full Text] [Related]
13. A study of therapeutic effect of the growth of children with hypothyroidism.
Bajracharya BL; Baral MR; Thapa Chhetri P
Kathmandu Univ Med J (KUMJ); 2006; 4(3):329-33. PubMed ID: 18603928
[TBL] [Abstract][Full Text] [Related]
14. The utility of FT4 serum in newborns at risk for congenital hypothyroidism (CH).
Cordova RA; Vignola G
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():152-3. PubMed ID: 15906723
[TBL] [Abstract][Full Text] [Related]
15. Repeat testing for congenital hypothyroidism in preterm infants is unnecessary with an appropriate thyroid stimulating hormone threshold.
Korada M; Pearce MS; Ward Platt MP; Avis E; Turner S; Wastell H; Cheetham T
Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F286-8. PubMed ID: 18252816
[TBL] [Abstract][Full Text] [Related]
16. Update on the management of congenital hypothyroidism.
Grüters A; Krude H
Horm Res; 2007; 68 Suppl 5():107-11. PubMed ID: 18174723
[TBL] [Abstract][Full Text] [Related]
17. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism.
Bongers-Schokking JJ; Koot HM; Wiersma D; Verkerk PH; de Muinck Keizer-Schrama SM
J Pediatr; 2000 Mar; 136(3):292-7. PubMed ID: 10700683
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of the plasma concentrations of TSH, FT4 and T3 following thyroxine supplementation in congenital hypothyroidism.
Bakker B; Kempers MJ; De Vijlder JJ; Van Tijn DA; Wiedijk BM; Van Bruggen M; Vulsma T
Clin Endocrinol (Oxf); 2002 Oct; 57(4):529-37. PubMed ID: 12354136
[TBL] [Abstract][Full Text] [Related]
19. Clinical monitoring guidelines for congenital hypothyroidism: laboratory outcome data in the first year of life.
Balhara B; Misra M; Levitsky LL
J Pediatr; 2011 Apr; 158(4):532-7. PubMed ID: 21094953
[TBL] [Abstract][Full Text] [Related]
20. Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH.
Selva KA; Harper A; Downs A; Blasco PA; Lafranchi SH
J Pediatr; 2005 Dec; 147(6):775-80. PubMed ID: 16356430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
